Designation of Dr. Ankur Bahl
Dr. Ankur Bahl
Medical Oncologist
Senior Director – Medical Oncology
Fortis Memorial Research Institute, Gurugram
Profile Snapshot of Dr. Ankur Bahl
- Dr. Ankur Bahl is a distinguished Senior Director of Medical Oncology at Fortis Memorial Research Institute (FMRI), Gurugram, with over 15 years of extensive experience in the field of oncology.
- Dr. Bahl completed his MBBS and MD in Medicine from Maulana Azad Medical College, Delhi. He further specialized by earning a DM in Medical Oncology from the prestigious All India Institute of Medical Sciences (AIIMS), New Delhi.
- His commitment to advancing his knowledge is evidenced by his completion of a specialized course on Adverse Drug Reactions, Drug Interactions, and Pharmacovigilance at the University of Oxford, UK.
- His clinical expertise encompasses a broad range of oncology treatments, including immunotherapy, targeted therapies combined with chemotherapy, hormonal therapy, as well as supportive and palliative care.
- Dr. Bahl has made significant contributions to the field through his research. He is the lead author of pivotal studies, including the largest real-world Indian data on targeted therapy (Cetuximab) in Head & Neck cancer, Acute Myeloid Leukemia treatment, and trends in Human Papillomavirus (HPV) in the Indian population.
- Prior to joining FMRI, Gurugram, Dr. Bahl served as the Director of Medical Oncology and Hematology Oncology at Max Hospital, Saket.
- He has also been associated with the Rajiv Gandhi Cancer Institute and Research Centre and Maulana Azad Medical College, further highlighting his extensive and varied experience in the field.
Dr. Ankur Bahl’s Expertise
- Immunotherapy
- Targeted therapies in combination with chemotherapy
- Hormonal therapy
- Supportive and palliative care
- Chemotherapy
- Lymphoma
- Breast Cancer
- Head & Neck cancer
- Acute Myeloid Leukemia treatment
Work Experience of Dr. Ankur Bahl
- Senior Director Medical Oncology and Hemato-Oncology at
- Director – Medical Oncology & Haematology oncology at Max Healthcare, Saket, Delhi India
- Senior Consultant, Medical Oncology and Hemato Oncology at Max Super Speciality Hospital
- Consultant Medical Oncology and Hemato Oncology at Max Super Speciality Hospital
- DM Medical Oncology at AIIMS, New Delhi, India
- DNB Fellow Department of Medical Oncology at Rajiv Gandhi Cancer Institute & Research Centre
- Senior Resident Department of Medicine at Maulana Azad Medical College
- MD Medicine at Maulana Azad Medical College
Dr. Ankur Bahl’s Qualifications
- DM – Oncology from All India Institute of Medical Sciences, New Delhi in 2012
- MD – Medicine from G B Pant Hospital / Moulana Azad Medical College, New Delhi in 2007
- MBBS from G B Pant Hospital / Moulana Azad Medical College, New Delhi in 2003
Awards & Recognitions received by Dr. Ankur Bahl
- Gold medal for best Outgoing Postgraduate student in department of Medicine
Memberships of Dr. Ankur Bahl
- American Society of Clinical Oncology (ASCO)
- European Society of Medical Oncology (ESMO)
- Indian Society of Medical and Paediatric Oncology (ISMPO)
Publications by Dr. Ankur Bahl
- A case of primary rectal non-Hodgkin's lymphoma treated with chemotherapy.Singla R, Kumar P, Bahl A, Kumar S, Saran RK, Kar P. Trop Gastroenterol
- Acute onset flaccid quadriparesis in pediatric non-Hodgkin lymphoma: vincristine induced or Guillain-Barré syndrome? Bahl A, Chakrabarty B, Gulati S, Raju KN, Raja A, Bakhshi S. Pediatr Blood Cancer.
- Autologous Stem Cell Transplantation for Multiple Myeloma: Identification of Prognostic Factors. Kumar L, Cyriac SL, Tejomurtula TV, Bahl A, Biswas B, Sahoo RK, Mukherjee A, Sharma O. Clin Lymphoma Myeloma Leuk.
- Carcinoma esophagus: a rare primary malignancy for ocular metastasis. Pal D, Bahl A, Sharma JB, Rao RR. Indian J Cancer.
- Dasatinib in chronic myeloid leukemia: A limited Indian experience. Sharma A,Bahl A,Raina V,Kumar L,Gupta R. Asia Pac J Clin Oncol
- Dengue Fever in patients with pediatric malignancy on chemotherapy: a concern in tropical countries. Bahl A, Bakhshi S. Pediatr Blood Cancer.